Precision Biosciences DTIL
NASDAQ DTIL
$9.15 -0.35 (-3.68%)
At close: Nov 11, 2026 · 4:00 PM EST

Precision Biosciences (DTIL) Income from Discontinued Operations (2022 - 2023)

Updated

Precision Biosciences' Income from Discontinued Operations came in at $885,000 for FY2025 (year ended Dec 31, 2025).

Analysis

Precision Biosciences (DTIL) Income from Discontinued Operations (2022 - 2023) Analysis & Trends

  • Per Business Quant, earlier fiscal years put Income from Discontinued Operations at -$18.79 million in FY2023 and -$38.73 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Precision Biosciences 264.98 Mn -121.18 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -2.86 Mn
Sep 30, 2023 4.03 Mn
Jun 30, 2023 -8.86 Mn
Mar 31, 2023 -11.11 Mn
Dec 31, 2022 -9.06 Mn
Sep 30, 2022 -8.26 Mn
API Access

Precision Biosciences Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=DTIL&period=max&api_key=YOUR_API_KEY